Literature DB >> 3283295

CT-assisted stereotactic brain biopsy: value of intraoperative frozen section diagnosis.

H J Colbassani1, S Nishio, K M Sweeney, R A Bakay, Y Takei.   

Abstract

In 100 recent CT-guided brain biopsies, the value of intraoperative histologic examination using frozen section technique was evaluated. In 87 of these cases, the biopsy was performed stereotactically. In the remaining 13 cases, a CT-guided free hand technique was used. Of the 100 biopsies performed, adequate tissue for histopathologic diagnosis was obtained in 97, and in three the biopsy was nondiagnostic. In 61 procedures the initial biopsy specimen was adequate for diagnosis. Two specimens were required in 25 and in the remaining cases it was necessary to obtain three to four biopsy specimens before a definitive diagnosis could be made. Ultimately, the histologic diagnosis was made on frozen section examination in 93 of the cases. The lesions identified were neoplastic disease in 83 cases, vascular disease in seven, infectious disease in five, demyelinating disease in one, and radiation necrosis in one. Comparison between the frozen section diagnosis and the final diagnosis based on the permanent sections revealed that they matched in 89 cases (92%). Of the 83 cases of neoplasms the exact grade of malignancy was determined by frozen section to make a final diagnosis revealed that even if the specimen volume was less than 2 mm3, the biopsy was generally successful. The disadvantages of the small sample size obtained through needle biopsy are best overcome by careful targeting and assessment of sample quality by intraoperative frozen section examinations, which will give the definitive diagnosis in most of the cases without paraffin-embedded sections.

Entities:  

Mesh:

Year:  1988        PMID: 3283295      PMCID: PMC1032857          DOI: 10.1136/jnnp.51.3.332

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  The nonspecificity of absorption coefficients in the differentiation of solid tumors and cystic lesions.

Authors:  R E Latchaw; L H Gold; J S Moore; J T Payne
Journal:  Radiology       Date:  1977-10       Impact factor: 11.105

2.  Stereotaxic Apparatus for Operations on the Human Brain.

Authors:  E A Spiegel; H T Wycis; M Marks; A J Lee
Journal:  Science       Date:  1947-10-10       Impact factor: 47.728

3.  Surgical options for patients with deep-seated brain tumors: computer-assisted stereotactic biopsy.

Authors:  P J Kelly; F Earnest; B A Kall; S J Goerss; B Scheithauer
Journal:  Mayo Clin Proc       Date:  1985-04       Impact factor: 7.616

4.  Computed tomographic guidance stereotaxis in the management of intracranial mass lesions.

Authors:  M L Apuzzo; J K Sabshin
Journal:  Neurosurgery       Date:  1983-03       Impact factor: 4.654

5.  Preliminary experience with Brown-Roberts-Wells (BRW) computerized tomography stereotaxic guidance system.

Authors:  M P Heilbrun; T S Roberts; M L Apuzzo; T H Wells; J K Sabshin
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

6.  MR recognition of supratentorial tumors.

Authors:  B C Lee; J B Kneeland; P T Cahill; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

7.  Magnetic resonance imaging of brain tumors: measurement of T1. Work in progress.

Authors:  T Araki; T Inouye; H Suzuki; T Machida; M Iio
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

8.  Stereotactic biopsy of brain tumors.

Authors:  C B Ostertag; H D Mennel; M Kiessling
Journal:  Surg Neurol       Date:  1980-10

9.  Difficulties in diagnosis of supratentorial gliomas by CAT scan.

Authors:  B E Kendall; J Jakubowski; P Pullicino; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

10.  Accuracy of CT scans in identifying tumor tissue.

Authors:  P W Hitchon; R L Schelper; T Barloon
Journal:  Appl Neurophysiol       Date:  1985
View more
  9 in total

1.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

2.  Correlation of Intraoperative Frozen Section Report and Histopathological Diagnosis of 
Central Nervous System Tumors - A Six-Year Retrospective Study.

Authors:  Radiya Al-Ajmi; Hunaina Al-Kindi; Mina George; Kurien Thomas
Journal:  Oman Med J       Date:  2016-11

3.  The value of per-operative smear examination during stereotactic biopsy.

Authors:  N D Kitchen; R Bradford; J E McLaughlin
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  Symptomatic intracranial hemorrhages and frame-based stereotactic brain biopsy.

Authors:  Monica Lara-Almunia; Javier Hernandez-Vicente
Journal:  Surg Neurol Int       Date:  2020-08-01

5.  Image directed stereotactic surgery for brain stem lesions.

Authors:  G P Kratimenos; R M Nouby; R Bradford; M F Pell; D G Thomas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

6.  Management strategies after nondiagnostic results with frameless stereotactic needle biopsy: Retrospective review of 28 patients.

Authors:  Ellen L Air; Ronald E Warnick; Christopher M McPherson
Journal:  Surg Neurol Int       Date:  2012-10-31

7.  A forward-imaging needle-type OCT probe for image guided stereotactic procedures.

Authors:  Chia-Pin Liang; Jeremiah Wierwille; Thais Moreira; Gary Schwartzbauer; M Samir Jafri; Cha-Min Tang; Yu Chen
Journal:  Opt Express       Date:  2011-12-19       Impact factor: 3.894

8.  The diagnostic properties of frozen sections in suspected intracranial tumors: A study of 578 consecutive cases.

Authors:  Kathrine Tofte; Cathrine Berger; Sverre Helge Torp; Ole Solheim
Journal:  Surg Neurol Int       Date:  2014-12-03

Review 9.  The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Daniel P Cahill; Andrew E Sloan; Brian V Nahed; Kenneth D Aldape; David N Louis; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.